Vigil Neuroscience Inc
NASDAQ:VIGL
Balance Sheet
Balance Sheet Decomposition
Vigil Neuroscience Inc
Current Assets | 106.5m |
Cash & Short-Term Investments | 101.6m |
Other Current Assets | 4.9m |
Non-Current Assets | 18.5m |
PP&E | 17.5m |
Other Non-Current Assets | 1.1m |
Current Liabilities | 8.6m |
Accounts Payable | 1.5m |
Accrued Liabilities | 7.1m |
Non-Current Liabilities | 12.7m |
Other Non-Current Liabilities | 12.7m |
Balance Sheet
Vigil Neuroscience Inc
Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|
Assets | |||||
Cash & Cash Equivalents |
24
|
91
|
187
|
52
|
|
Cash Equivalents |
24
|
91
|
187
|
52
|
|
Short-Term Investments |
0
|
0
|
0
|
66
|
|
Other Current Assets |
1
|
6
|
11
|
4
|
|
Total Current Assets |
25
|
98
|
198
|
122
|
|
PP&E Net |
0
|
1
|
1
|
18
|
|
PP&E Gross |
0
|
0
|
1
|
18
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
4
|
1
|
1
|
|
Total Assets |
25
N/A
|
102
+305%
|
200
+96%
|
141
-30%
|
|
Liabilities | |||||
Accounts Payable |
1
|
4
|
2
|
2
|
|
Accrued Liabilities |
1
|
6
|
9
|
10
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
2
|
10
|
11
|
12
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
|
Other Liabilities |
5
|
0
|
0
|
13
|
|
Total Liabilities |
7
N/A
|
10
+52%
|
11
+14%
|
25
+118%
|
|
Equity | |||||
Common Stock |
47
|
162
|
0
|
0
|
|
Retained Earnings |
29
|
72
|
140
|
223
|
|
Additional Paid In Capital |
0
|
2
|
329
|
339
|
|
Other Equity |
0
|
0
|
0
|
0
|
|
Total Equity |
19
N/A
|
93
+392%
|
189
+104%
|
116
-39%
|
|
Total Liabilities & Equity |
25
N/A
|
102
+305%
|
200
+96%
|
141
-30%
|
|
Shares Outstanding | |||||
Common Shares Outstanding |
28
|
28
|
36
|
36
|